Developer docs
API playgroundTry for free, no card

Search company profiles

GenQA

Full company profile

uuid002913l

Namestring
GenQA
Legal namestring
GenQA
Websiteurl
genqa.org
Company typeenum
Private
Founded yearint
1982
Descriptiontext

GenQA is a not-for-profit External Quality Assessment (EQA) and Proficiency Testing provider serving the clinical genomics community worldwide. Operated by Oxford University NHS Foundation Trust and operating as part of the UK NEQAS consortium, the organization delivers over 120 EQA schemes across 13 genomics disciplines (including clinical genetics, haematological neoplasms, molecular pathology, pharmacogenomics, viral sequencing, and reproductive genomics), reaching 2,600 participating laboratories across 101 countries and supported by 237 expert scientific advisors. Most schemes are accredited to ISO 17043, and the organization holds the NHS England contract for EQA delivery against the full National Genomic Test Directory.

The company's core technology platform is GENie, an online genomic education and competency assessment tool covering HGVS and ISCN nomenclature, germline and somatic variant classification (SNV/CNV/BRCA/HRR), risk calculations, WGS/WES proportionate variant analysis, and tumour tissue assessment (Tissue-i). The platform delivers instant automated scoring, randomized scenarios, and CPD/CME hours, with individual access priced at £35 per year and laboratory multi-licences at £330 per year for 10 users. GenQA monetizes through subscription-based EQA scheme participation fees (variable by programme, with early bird discounts and 30% emerging-economy reductions), individual and institutional GENie subscriptions, and the NHS England EQA contract; certain modules (e.g., BRCA/HRR classification) are offered free of charge under educational grants from AstraZeneca and MSD.

GenQA distributes primarily through direct enrolment via its member portal at eqa.genqa.org, supported by multilingual submission capability across seven languages, an active conference and webinar programme, and channel partnerships with Swiss CSCQ (for Swiss national certification) and UK NEQAS for Microbiology (for SARS-CoV-2 sequencing). Customer concentration sits between large institutional anchors (NHS England, AstraZeneca) and a long tail of 2,600 laboratories globally; growth has been measured and product-led, with three new GENie modules scheduled or launched in 2026 and ongoing geographic expansion into non-Anglophone and emerging markets.

Short descriptiontext

GenQA is a not-for-profit External Quality Assessment and Proficiency Testing provider for clinical genomics, operated by Oxford University NHS Foundation Trust as part of UK NEQAS. It delivers over 120 ISO 17043-accredited EQA schemes and the GENie competency assessment platform to 2,600 laboratories across 101 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEdinburgh, United Kingdom
HQ citystring
Edinburgh
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
external quality assessment, proficiency testing services, clinical genomics EQA, variant classification assessment, laboratory accreditation testing
Industry3 codes
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Genomics Quality Assessment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1EQA Scheme Participation Fees
TypeSubscription Recurring
Description

GenQA charges laboratories for participation in External Quality Assessment schemes. Fees are based on annual EQA programme enrolment. Discounts available for emerging economies (30% reduction for 5 years for IMF-defined emerging and developing economies).

genqa.org
2GENie Individual Licences
TypeSubscription Recurring
Description

Individual genomics professionals can purchase GENie training access (all modules) for £35 per 12 months. Includes HGVS Nomenclature, ISCN, CNV/SNV Classification, Risk Calculations, Tumour Variant Classification, and WGS/WES Proportionate Variant Analysis.

genqa.org
3GENie Laboratory Multi-Licences
TypeSubscription Recurring
Description

Laboratories or clinical centres can purchase multi-licences for GENie for 10 users, costed at £330 per calendar year, including access to all modules.

genqa.org
4BRCA/HRR Classification Module (Free)
TypeSubscription Recurring
Description

The BRCA and HRR gene variant classification module is provided at no fee to participants, supported through an educational grant by AstraZeneca and MSD.

genqa.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Pricing details4 tiers
1GENie Individual Licence – £35 for 12 months
ModelSubscriptionBilling cadenceAnnual
Notes

Individual genomics professionals get access to all GENie modules (HGVS Nomenclature, ISCN, CNV/SNV Classification, Risk Calculations, Tumour Variant Classification, WGS/WES Proportionate Variant Analysis) for £35 per 12 months. Purchased via PayPal.

genqa.org
2GENie Laboratory Multi-Licence – £330 for 10 users per calendar year
ModelSubscriptionBilling cadenceAnnual
Notes

Laboratories or clinical centres can purchase multi-licences for 10 users at £330 per calendar year. Includes access to all GENie modules. Tokens expire at midnight on 1st January each year.

genqa.org
3EQA Scheme Fees – Variable by programme
ModelSubscriptionBilling cadenceAnnual
Notes

EQA participation fees vary by programme. Early bird discounts available. 30% reduction for laboratories from IMF-defined emerging and developing economies for five years (conditional on continued participation at full cost for minimum 2 further years). 2026 EQA price list valid 1st April 2026 – 31st March 2027.

genqa.org
4BRCA/HRR Classification Module – Free
ModelFreemiumBilling cadenceAnnual
Notes

No fee to participate in the BRCA/HRR classification module. Supported through an educational grant by AstraZeneca and MSD.

genqa.org
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1GENie
Description

A specialist genomic education and assessment tool providing end-to-end competency assessments for genomics professionals, including HGVS Nomenclature, ISCN, CNV/SNV Classification, Risk Calculations, Tumour Variant Classification, and WGS/WES Proportionate Variant Analysis modules.

genqa.org
+1 more record
Core offering1 text field

GenQA provides External Quality Assessment (EQA) and Proficiency Testing services to clinical genomics laboratories worldwide, delivering over 120 EQAs across 13 disciplines including clinical genetics, haematological neoplasms, molecular pathology, pharmacogenomics, technical NGS, variant classification, and viral sequencing. The organisation also operates GENie, an online competency assessment tool for individual genomics professionals covering HGVS/ISCN nomenclature, germline and somatic variant classification, BRCA/HRR gene variants, risk calculations, WGS/WES proportionate variant analysis, and tissue assessment.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 2600 laboratories participate in GenQA EQAs across 101 countries
+3 more records
Product overview1 text field

GenQA is a not-for-profit External Quality Assessment (EQA)/Proficiency Testing provider offering over 120 genomics EQAs. The core product portfolio consists of two main offerings: (1) External Quality Assessment (EQA) Programs covering entire clinical genomics service across 13 disciplines including Clinical Genetics, Haematological Neoplasms, Molecular Pathology, Pharmacogenomics, Technical NGS, Variant Classification, and Viral Sequencing; and (2) GENie, a specialist genomic education and assessment tool providing individual competency testing modules. GENie modules include HGVS/ISCN Nomenclature Assessment, Germline Variant Classification (SNV/CNV), BRCA1/BRCA2 & HRR Gene Variants, Somatic Variant Classification, Risk Calculations, WGS/WES Proportionate Variant Analysis, and Tissue-i for tumour annotation. Most EQAs are accredited to ISO 17043 standard and the organization is operated by Oxford University NHS Foundation Trust as part of UK NEQAS.

Product and service1 record
1GENie (Genomic Education and Assessment Tool)
CategoryIndividual Competency Assessment Platform
Description

Online competency assessment platform providing end-to-end individual genomic competency assessment with modules for variant classification, nomenclature, risk calculations, WGS/WES analysis, and tissue assessment. Individual licence £35/12 months; laboratory multi-licence £330 for 10 users per calendar year.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
1Swiss Centre for Quality Control (CSCQ), Geneva
Strategic tierRegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2017-01-01
Description

CSCQ collaborates with GenQA on request of the Swiss Society of Medical Genetics (SSMG). GenQA develops and coordinates EQA services; CSCQ is responsible for dispatching GenQA scheme samples to Swiss medical laboratories and reviews evaluations together with SSMG to provide official certificates required by Swiss law. This collaboration has been successful since 2017.

genqa.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

GenQA is operated as part of the UK NEQAS consortium, governed by Oxford University NHS Foundation Trust. UK NEQAS provides EQA services for over 50 years (since 1969) across haematology, microbiology, clinical chemistry, genetic testing, cellular pathology, reproductive science and immunology with 324 EQA programmes. UK NEQAS services have been used by over 100,000 clinical laboratory scientists and healthcare professionals in more than 150 countries.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

GenQA is operated by Oxford University NHS Foundation Trust, which provides institutional governance, scientific leadership, and operational infrastructure for the EQA programmes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

GenQA collaborates with EMQN on BRCA and HRR gene variant classification assessments. These assessments take place in spring and autumn each year. EMQN provides additional expertise and reach for this specific programme area.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

GenQA collaborates with UK NEQAS for Microbiology on SARS-CoV-2 viral genome sequencing EQA. Participants register with UK NEQAS for Microbiology for this programme, which handles all invoicing and shipment costs. GenQA provides the sequencing analysis assessment.

Strategic tierMinorTypeGTM or Marketing Partner
Description

AstraZeneca provided an educational grant supporting the BRCA/HRR variant classification module and co-developed variant interpretation resource materials (Variant Interpretation Resource Card). AstraZeneca has also collaborated with GenQA on BRCA testing EQA for ovarian cancer. Lee Welch, AstraZeneca UK, serves as a customer testimonial.

7MSD
Strategic tierMinorTypeGTM or Marketing Partner
Description

MSD co-funded the BRCA and HRR gene variant classification module as an educational grant partner alongside AstraZeneca. The educational content was co-developed and funded by AstraZeneca and MSD.

genqa.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1QCMD (Quality Control for Molecular Diagnostics)
TypeDirect peer
Description

Independent international EQA provider for molecular diagnostics including viral sequencing, respiratory pathogens, and emerging infections - directly comparable to GenQA's viral sequencing and molecular pathology programmes.

TypeBroad incumbent
Description

US-based pathology accreditation and proficiency testing body offering molecular genetics and genomics EQA programmes as part of a much broader laboratory quality portfolio - overlapping capability, much larger organization.

3RCPAQAP (Royal College of Pathologists of Australasia Quality Assurance Programs)
TypeRegional player
Description

Australasian EQA provider with molecular genetics and genomics programmes - comparable in scope but regionally focused on Australia/New Zealand/Asia-Pacific.

TypeEmerging player
Description

Pharmacogenomics-focused clinical service and software company - adjacent to GenQA's pharmacogenomics EQA scope and representing the type of technology-driven entrant that could disrupt traditional EQA models.

TypeDirect peer
Description

German non-profit providing EQA across multiple laboratory disciplines including molecular genetics and genomics - a directly comparable European EQA provider competing for the same lab customers.

TypeDirect peer
Description

Finnish-based international EQA provider offering proficiency testing across clinical chemistry, microbiology, and molecular genetics - comparable multi-discipline EQA model to UK NEQAS/GenQA.

TypeDirect peer
Description

European provider of EQA schemes for molecular genetics including BRCA/HRR variant classification - a direct programme-level peer to GenQA, and explicitly listed as a collaboration partner on GenQA's BRCA/HRR module.

TypeDirect peer
Description

UK National External Quality Assessment Service - GenQA's parent consortium, providing 324 EQA programmes across haematology, microbiology, chemistry, immunology, cellular pathology, and genomics with 100,000+ professionals served in 150+ countries.

9Swiss Centre for Quality Control (CSCQ)
TypeRegional player
Description

Swiss national EQA provider collaborating with GenQA on Swiss genomic EQA schemes since 2017 - functionally a regional channel/reseller partner and direct peer within Switzerland.

10EQUALIS (External Quality Assurance in Laboratory Medicine in Sweden)
TypeRegional player
Description

Swedish non-profit EQA provider covering clinical chemistry, microbiology, and molecular genetics including genomics - directly comparable service model, geographically focused on Nordics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers14 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GenQA

Clinical Genomics Quality Assessmentgenqa.org

GenQA is a not-for-profit External Quality Assessment and Proficiency Testing provider for clinical genomics, operated by Oxford University NHS Foundation Trust as part of UK NEQAS. It delivers over 120 ISO 17043-accredited EQA schemes and the GENie competency assessment platform to 2,600 laboratories across 101 countries.

What GenQA does

GenQA is a not-for-profit External Quality Assessment (EQA) and Proficiency Testing provider serving the clinical genomics community worldwide. Operated by Oxford University NHS Foundation Trust and operating as part of the UK NEQAS consortium, the organization delivers over 120 EQA schemes across 13 genomics disciplines (including clinical genetics, haematological neoplasms, molecular pathology, pharmacogenomics, viral sequencing, and reproductive genomics), reaching 2,600 participating laboratories across 101 countries and supported by 237 expert scientific advisors. Most schemes are accredited to ISO 17043, and the organization holds the NHS England contract for EQA delivery against the full National Genomic Test Directory.

The company's core technology platform is GENie, an online genomic education and competency assessment tool covering HGVS and ISCN nomenclature, germline and somatic variant classification (SNV/CNV/BRCA/HRR), risk calculations, WGS/WES proportionate variant analysis, and tumour tissue assessment (Tissue-i). The platform delivers instant automated scoring, randomized scenarios, and CPD/CME hours, with individual access priced at £35 per year and laboratory multi-licences at £330 per year for 10 users. GenQA monetizes through subscription-based EQA scheme participation fees (variable by programme, with early bird discounts and 30% emerging-economy reductions), individual and institutional GENie subscriptions, and the NHS England EQA contract; certain modules (e.g., BRCA/HRR classification) are offered free of charge under educational grants from AstraZeneca and MSD.

GenQA distributes primarily through direct enrolment via its member portal at eqa.genqa.org, supported by multilingual submission capability across seven languages, an active conference and webinar programme, and channel partnerships with Swiss CSCQ (for Swiss national certification) and UK NEQAS for Microbiology (for SARS-CoV-2 sequencing). Customer concentration sits between large institutional anchors (NHS England, AstraZeneca) and a long tail of 2,600 laboratories globally; growth has been measured and product-led, with three new GENie modules scheduled or launched in 2026 and ongoing geographic expansion into non-Anglophone and emerging markets.

GenQA firmographics

Firmographics
Name
GenQA
Legal name
GenQA
Website
https://genqa.org
Company type
Private
Founded year
1982
Operating status
Operating
Headcount range
11–50 employees
Short description
GenQA is a not-for-profit External Quality Assessment and Proficiency Testing provider for clinical genomics, operated by Oxford University NHS Foundation Trust as part of UK NEQAS. It delivers over 120 ISO 17043-accredited EQA schemes and the GENie competency assessment platform to 2,600 laboratories across 101 countries.
Ownership category
akta.pro rank

GenQA industry classification

Industry
Product category
Clinical Genomics Quality Assessment
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories

Keywords

  • External quality assessment
  • Proficiency testing services
  • Clinical genomics EQA
  • Variant classification assessment
  • Laboratory accreditation testing

Where GenQA is headquartered

Location

Headquarters

HQ city
Edinburgh
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

GenQA business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

  1. EQA Scheme Participation Fees: GenQA charges laboratories for participation in External Quality Assessment schemes. Fees are based on annual EQA programme enrolment. Discounts available for emerging economies (30% reduction for 5 years for IMF-defined emerging and developing economies).
  2. GENie Individual Licences: Individual genomics professionals can purchase GENie training access (all modules) for £35 per 12 months. Includes HGVS Nomenclature, ISCN, CNV/SNV Classification, Risk Calculations, Tumour Variant Classification, and WGS/WES Proportionate Variant Analysis.
  3. GENie Laboratory Multi-Licences: Laboratories or clinical centres can purchase multi-licences for GENie for 10 users, costed at £330 per calendar year, including access to all modules.
  4. BRCA/HRR Classification Module (Free): The BRCA and HRR gene variant classification module is provided at no fee to participants, supported through an educational grant by AstraZeneca and MSD.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualGENie Individual Licence – £35 for 12 months
SubscriptionAnnualGENie Laboratory Multi-Licence – £330 for 10 users per calendar year
SubscriptionAnnualEQA Scheme Fees – Variable by programme
FreemiumAnnualBRCA/HRR Classification Module – Free

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

GenQA product offering

Product offering

Core offering

GenQA provides External Quality Assessment (EQA) and Proficiency Testing services to clinical genomics laboratories worldwide, delivering over 120 EQAs across 13 disciplines including clinical genetics, haematological neoplasms, molecular pathology, pharmacogenomics, technical NGS, variant classification, and viral sequencing. The organisation also operates GENie, an online competency assessment tool for individual genomics professionals covering HGVS/ISCN nomenclature, germline and somatic variant classification, BRCA/HRR gene variants, risk calculations, WGS/WES proportionate variant analysis, and tissue assessment.

Product overview

GenQA is a not-for-profit External Quality Assessment (EQA)/Proficiency Testing provider offering over 120 genomics EQAs. The core product portfolio consists of two main offerings: (1) External Quality Assessment (EQA) Programs covering entire clinical genomics service across 13 disciplines including Clinical Genetics, Haematological Neoplasms, Molecular Pathology, Pharmacogenomics, Technical NGS, Variant Classification, and Viral Sequencing; and (2) GENie, a specialist genomic education and assessment tool providing individual competency testing modules. GENie modules include HGVS/ISCN Nomenclature Assessment, Germline Variant Classification (SNV/CNV), BRCA1/BRCA2 & HRR Gene Variants, Somatic Variant Classification, Risk Calculations, WGS/WES Proportionate Variant Analysis, and Tissue-i for tumour annotation. Most EQAs are accredited to ISO 17043 standard and the organization is operated by Oxford University NHS Foundation Trust as part of UK NEQAS.

Differentiator

Problem solved

Functional benefit

Brands

  • GENie: A specialist genomic education and assessment tool providing end-to-end competency assessments for genomics professionals, including HGVS Nomenclature, ISCN, CNV/SNV Classification, Risk Calculations, Tumour Variant Classification, and WGS/WES Proportionate Variant Analysis modules.
  • Tissue-i

Products and services

  • GENie (Genomic Education and Assessment Tool) Online competency assessment platform providing end-to-end individual genomic competency assessment with modules for variant classification, nomenclature, risk calculations, WGS/WES analysis, and tissue assessment. Individual licence £35/12 months; laboratory multi-licence £330 for 10 users per calendar year.

Quantifiable outcome

  • 2600 laboratories participate in GenQA EQAs across 101 countries
  • +3 more outcomes

Companies that use GenQA

Customer profile

Named customers14 records

Segments5 records

Ideal customer profiles5 records

GenQA technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

GenQA partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered regional, core and minor.

  • Swiss Centre for Quality Control (CSCQ), GenevaregionalChannel Partner/ Reseller/ Distributor · 1 January 2017CSCQ collaborates with GenQA on request of the Swiss Society of Medical Genetics (SSMG). GenQA develops and coordinates EQA services; CSCQ is responsible for dispatching GenQA scheme samples to Swiss medical laboratories and reviews evaluations together with SSMG to provide official certificates required by Swiss law. This collaboration has been successful since 2017.
  • UK NEQAScoreStrategic or Co-development PartnerGenQA is operated as part of the UK NEQAS consortium, governed by Oxford University NHS Foundation Trust. UK NEQAS provides EQA services for over 50 years (since 1969) across haematology, microbiology, clinical chemistry, genetic testing, cellular pathology, reproductive science and immunology with 324 EQA programmes. UK NEQAS services have been used by over 100,000 clinical laboratory scientists and healthcare professionals in more than 150 countries.
  • Oxford University NHS Foundation TrustcoreStrategic or Co-development PartnerGenQA is operated by Oxford University NHS Foundation Trust, which provides institutional governance, scientific leadership, and operational infrastructure for the EQA programmes.
  • EMQN (European Molecular Genetics Quality Network)coreStrategic or Co-development PartnerGenQA collaborates with EMQN on BRCA and HRR gene variant classification assessments. These assessments take place in spring and autumn each year. EMQN provides additional expertise and reach for this specific programme area.
  • UK NEQAS for MicrobiologyminorStrategic or Co-development PartnerGenQA collaborates with UK NEQAS for Microbiology on SARS-CoV-2 viral genome sequencing EQA. Participants register with UK NEQAS for Microbiology for this programme, which handles all invoicing and shipment costs. GenQA provides the sequencing analysis assessment.
  • AstraZenecaminorGTM or Marketing PartnerAstraZeneca provided an educational grant supporting the BRCA/HRR variant classification module and co-developed variant interpretation resource materials (Variant Interpretation Resource Card). AstraZeneca has also collaborated with GenQA on BRCA testing EQA for ovarian cancer. Lee Welch, AstraZeneca UK, serves as a customer testimonial.
  • MSDminorGTM or Marketing PartnerMSD co-funded the BRCA and HRR gene variant classification module as an educational grant partner alongside AstraZeneca. The educational content was co-developed and funded by AstraZeneca and MSD.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

GenQA competitors and assessment

Company assessment

Direct peers

  • QCMD (Quality Control for Molecular Diagnostics): Independent international EQA provider for molecular diagnostics including viral sequencing, respiratory pathogens, and emerging infections - directly comparable to GenQA's viral sequencing and molecular pathology programmes.
  • INSTAND e.V. German non-profit providing EQA across multiple laboratory disciplines including molecular genetics and genomics - a directly comparable European EQA provider competing for the same lab customers.
  • Labquality: Finnish-based international EQA provider offering proficiency testing across clinical chemistry, microbiology, and molecular genetics - comparable multi-discipline EQA model to UK NEQAS/GenQA.
  • EMQN (European Molecular Genetics Quality Network): European provider of EQA schemes for molecular genetics including BRCA/HRR variant classification - a direct programme-level peer to GenQA, and explicitly listed as a collaboration partner on GenQA's BRCA/HRR module.
  • UK NEQAS (parent consortium): UK National External Quality Assessment Service - GenQA's parent consortium, providing 324 EQA programmes across haematology, microbiology, chemistry, immunology, cellular pathology, and genomics with 100,000+ professionals served in 150+ countries.

Broad incumbents

  • College of American Pathologists (CAP): US-based pathology accreditation and proficiency testing body offering molecular genetics and genomics EQA programmes as part of a much broader laboratory quality portfolio - overlapping capability, much larger organization.

Regional players

  • RCPAQAP (Royal College of Pathologists of Australasia Quality Assurance Programs): Australasian EQA provider with molecular genetics and genomics programmes - comparable in scope but regionally focused on Australia/New Zealand/Asia-Pacific.
  • Swiss Centre for Quality Control (CSCQ): Swiss national EQA provider collaborating with GenQA on Swiss genomic EQA schemes since 2017 - functionally a regional channel/reseller partner and direct peer within Switzerland.
  • EQUALIS (External Quality Assurance in Laboratory Medicine in Sweden): Swedish non-profit EQA provider covering clinical chemistry, microbiology, and molecular genetics including genomics - directly comparable service model, geographically focused on Nordics.

Emerging players

  • OneOme (genomic interpretation/PGx): Pharmacogenomics-focused clinical service and software company - adjacent to GenQA's pharmacogenomics EQA scope and representing the type of technology-driven entrant that could disrupt traditional EQA models.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

GenQA social profiles

Digital presence

GenQA compliance and trust

Trust signal

Compliance2 records

GenQA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GenQA leadership team

Management profile

Number of profiles

GenQA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GenQA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GenQA

What does GenQA do?

GenQA provides External Quality Assessment (EQA) and Proficiency Testing services to clinical genomics laboratories worldwide, delivering over 120 EQAs across 13 disciplines including clinical genetics, haematological neoplasms, molecular pathology, pharmacogenomics, technical NGS, variant classification, and viral sequencing. The organisation also operates GENie, an online competency assessment tool for individual genomics professionals covering HGVS/ISCN nomenclature, germline and somatic variant classification, BRCA/HRR gene variants, risk calculations, WGS/WES proportionate variant analysis, and tissue assessment.

Is GenQA a public or private company?

GenQA is a private company. It is classified as state government owned and is currently operating.

When was GenQA founded?

GenQA was founded in 1982. It employs 11 to 50 people.

Where is GenQA based?

GenQA is headquartered in Edinburgh, United Kingdom, in the Europe region.

How does GenQA make money?

Four revenue lines are on record. EQA Scheme Participation Fees are the primary driver. The others are GENie Individual Licences, GENie Laboratory Multi-Licences and BRCA/HRR Classification Module (Free).

Who are GenQA's main competitors?

Direct peers on record are QCMD (Quality Control for Molecular Diagnostics), INSTAND e.V., Labquality, EMQN (European Molecular Genetics Quality Network) and UK NEQAS (parent consortium). College of American Pathologists (CAP) is listed as a broad incumbent. Regional players are RCPAQAP (Royal College of Pathologists of Australasia Quality Assurance Programs), Swiss Centre for Quality Control (CSCQ) and EQUALIS (External Quality Assurance in Laboratory Medicine in Sweden). OneOme (genomic interpretation/PGx) is listed as an emerging player.

Does GenQA have an API?

No public API is recorded for GenQA.

What industry is GenQA in?

GenQA's product category is Clinical Genomics Quality Assessment. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAGAEAD, Genomics & Molecular Diagnostics (Trial Support). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales